James E. Flynn - Director, Director by Deputization, 10%+ Owner at Nuvalent, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, Director by Deputization, 10%+ Owner
Stock Symbol
NUVL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James E. Flynn since 9/16/2023

Holdings reported by James E. Flynn for Nuvalent, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 9.67M $796M $82.33 Jun 12, 2024 Through Deerfield Healthcare Innovations Fund, L.P.
Class A Common Stock 9.67M $796M $82.33 Jun 12, 2024 Through Deerfield Private Design Fund IV, L.P.
Class A Common Stock 650K $53.5M $82.33 Jun 12, 2024 Deerfield Partners, L.P.
Class A Common Stock 2.5K $206K $82.33 Jun 12, 2024 Through Deerfield Management Company, L.P.
Stock Option (Right to Buy) 3.79K Jun 12, 2024 Through Deerfield Management Company, L.P. Class A Common Stock

Transactions reported by James E. Flynn for Nuvalent, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.